Causaly announced new scientific AI agents that provide research teams with the industry's most comprehensive biomedical knowledge for drug discovery. With agentic AI in...
Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress...
AZmed, one of the leading AI companies in medical imaging, announced that it has received two new U.S. Food and Drug Administration (FDA) clearances...
Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical...
AIRA Matrix, a leading innovator in AI-driven QC solutions, and Gestalt, an industry leader in IMS and digital pathology, have formed a strategic partnership...
Leveraging NVIDIA's Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization
Medical imaging faces several critical challenges. Imaging modalities like MRI,...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully secured a $110 million Series E financing led...
Caliber has launched four digital solutions that strengthen its portfolio and position the company at the forefront of the Pharma 4.0 revolution. These innovations integrate...
Flagship Pioneering, the bioplatform innovation company, unveiled Lila Sciences, a company building the world's first scientific superintelligence platform and fully autonomous labs for life,...
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced to unveil its innovative AI-assisted drug discovery...